The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer

SIMPLE SUMMARY: Although immune-stimulatory and targeted therapies benefit many patients with metastatic kidney cancer, a sizeable proportion of patients fail to respond. Recent studies in mice demonstrate that nutrient-limiting dietary interventions can improve responses to chemotherapy. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Orlandella, Rachael M., Turbitt, William J., Gibson, Justin T., Boi, Shannon K., Li, Peng, Smith, Daniel L., Norian, Lyse A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601245/
https://www.ncbi.nlm.nih.gov/pubmed/33036247
http://dx.doi.org/10.3390/cancers12102872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601245/
https://www.ncbi.nlm.nih.gov/pubmed/33036247
http://dx.doi.org/10.3390/cancers12102872

Ejemplares similares